InsiderTrades.com logo

XENE Insider Trading

Insider Ownership Percentage: 4.07%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $21,773,584.53

Xenon Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Xenon Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Xenon Pharmaceuticals Share Price & Price History

Current Price: $54.94
Price Change: ▼ Price Decrease of -0.23 (-0.42%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for XENE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Xenon Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/13/2026Andrea DiFabioInsiderSell1,342$55.23$74,118.667,301View SEC Filing Icon  
3/13/2026Christopher John KenneyInsiderSell1,410$55.23$77,874.307,069View SEC Filing Icon  
3/13/2026Ian MortimerCEOSell7,308$55.23$403,620.8419,923View SEC Filing Icon  
3/10/2026Andrea DiFabioInsiderSell2,607$60.11$156,706.774,893View SEC Filing Icon  
3/10/2026Christopher John KenneyInsiderSell2,771$60.11$166,564.814,729View SEC Filing Icon  
3/10/2026Ian MortimerCEOSell11,269$60.11$677,379.5914,731View SEC Filing Icon  
3/9/2026Ian MortimerCEOSell270,000$60.33$16,289,100.006,000View SEC Filing Icon  
1/2/2026Ian MortimerCEOSell40,000$44.43$1,777,200.006,000View SEC Filing Icon  
12/8/2025Ian MortimerCEOSell10,830$45.73$495,255.906,000View SEC Filing Icon  
12/5/2025Ian MortimerCEOSell14,375$45.03$647,306.2516,830View SEC Filing Icon  
11/28/2025Ian MortimerCEOSell97$45.01$4,365.9731,205View SEC Filing Icon  
10/1/2025Ian MortimerCEOSell25,000$40.16$1,004,000.0031,302View SEC Filing Icon  
6/5/2025Steven GannonDirectorSell3$30.48$91.447,141View SEC Filing Icon  
1/27/2025Ian MortimerCEOSell16,315$40.50$660,757.5031,302View SEC Filing Icon  
1/24/2025Ian MortimerCEOSell22,468$40.20$903,213.6031,302View SEC Filing Icon  
12/18/2024Sherry AulinCFOSell18,709$41.21$770,997.89View SEC Filing Icon  
11/22/2024Gary PatouDirectorSell4,891$41.08$200,922.2823,573View SEC Filing Icon  
3/7/2024Robin SherringtonEVPSell7,137$46.28$330,300.368,398View SEC Filing Icon  
3/7/2024Steven GannonDirectorSell13,000$46.28$601,640.002,000View SEC Filing Icon  
12/13/2023Gary PatouDirectorSell11,380$39.29$447,120.2023,573View SEC Filing Icon  
8/24/2023Dawn SvoronosDirectorSell25,000$38.70$967,500.0025,000View SEC Filing Icon  
5/31/2023Simon N. PimstoneDirectorSell62,526$38.70$2,419,756.206,000View SEC Filing Icon  
5/24/2023Ian MortimerCEOSell31,655$41.41$1,310,833.5524,213View SEC Filing Icon  
3/24/2023Christopher John KenneyInsiderSell700$35.01$24,507.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Xenon Pharmaceuticals (NASDAQ:XENE)

95.45% of Xenon Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at XENE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Xenon Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/17/2026Rockefeller Capital Management L.P.1,100$49K0.0%+450.0%0.001%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC25,109$1.13M0.0%N/A0.030%Search for SEC Filing on Google Icon
3/3/2026Caitong International Asset Management Co. Ltd1,225$55K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/19/2026T. Rowe Price Investment Management Inc.547,613$24.55M0.0%-8.6%0.709%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.50,947$2.28M0.0%-9.1%0.066%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC25,109$1.13M0.0%N/A0.032%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp4,772$0.21M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/18/2026ADAR1 Capital Management LLC203,969$9.14M0.7%+7.9%0.264%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd21,498$0.96M0.0%N/A0.028%Search for SEC Filing on Google Icon
2/18/2026Vestal Point Capital LP600,000$26.89M0.9%-45.5%0.776%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC6,037$0.27M0.1%+74.0%0.008%Search for SEC Filing on Google Icon
2/18/2026Squadron Capital Management LLC105,551$4.73M2.0%N/A0.137%Search for SEC Filing on Google Icon
2/18/2026Orbimed Advisors LLC447,200$20.04M0.4%+6.6%0.579%Search for SEC Filing on Google Icon
2/18/2026Oxford Asset Management LLP7,379$0.33M0.1%-66.7%0.010%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC635,056$28.46M0.0%-56.2%0.822%Search for SEC Filing on Google Icon
2/18/2026Man Group plc114,826$5.15M0.0%+396.7%0.149%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC4,084,034$183.11M0.1%+3.6%5.285%Search for SEC Filing on Google Icon
2/18/2026Eversept Partners LP231,380$10.37M0.5%N/A0.299%Search for SEC Filing on Google Icon
2/18/2026Cinctive Capital Management LP23,317$1.05M0.1%+1.1%0.030%Search for SEC Filing on Google Icon
2/18/2026Commodore Capital LP1,800,000$80.68M5.4%-33.3%2.329%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.84,360$3.78M0.0%-73.8%0.109%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC203,969$9.14M0.7%+7.9%0.264%Search for SEC Filing on Google Icon
2/17/2026Braidwell LP1,825,076$81.80M2.6%-49.4%2.362%Search for SEC Filing on Google Icon
2/17/2026Abel Hall LLC6,757$0.30M0.1%N/A0.009%Search for SEC Filing on Google Icon
2/17/2026Lazard Asset Management LLC78,663$3.53M0.0%N/A0.102%Search for SEC Filing on Google Icon
2/17/2026MPM Bioimpact LLC485,620$21.77M2.5%-3.5%0.628%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC173,882$7.79M0.0%-31.1%0.225%Search for SEC Filing on Google Icon
2/17/2026Amundi4,609$0.21M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC30,987$1.39M0.0%+376.7%0.040%Search for SEC Filing on Google Icon
2/17/2026Iron Triangle Partners LP233,688$10.47M1.2%N/A0.302%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD862,300$38.65M0.0%+1,968.3%1.116%Search for SEC Filing on Google Icon
2/17/2026T. Rowe Price Investment Management Inc.92,547$4.15M0.0%-84.6%0.120%Search for SEC Filing on Google Icon
2/17/2026Rock Springs Capital Management LP787,788$35.31M1.8%-7.5%1.019%Search for SEC Filing on Google Icon
2/17/2026Himension Capital Singapore PTE. LTD.11,279$0.51M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.685,100$30.71M0.0%-18.0%0.887%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System56,564$2.54M0.0%-6.1%0.073%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.86,220$3.86M0.0%+23.4%0.112%Search for SEC Filing on Google Icon
2/17/2026Granahan Investment Management LLC92,778$4.16M0.2%+6.1%0.120%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board205,569$9.21M0.0%-1.3%0.266%Search for SEC Filing on Google Icon
2/17/2026Avoro Capital Advisors LLC5,424,444$243.12M2.3%+0.5%6.521%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada89,757$4.02M0.0%-25.5%0.116%Search for SEC Filing on Google Icon
2/17/2026Magnetar Financial LLC5,153$0.23M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/17/2026Polar Capital Holdings Plc2,465,694$110.51M0.4%-3.2%3.191%Search for SEC Filing on Google Icon
2/16/2026Sofinnova Investments Inc.59,900$2.69M0.1%N/A0.078%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC93,756$4.20M0.0%+64.1%0.121%Search for SEC Filing on Google Icon
2/16/2026NEXTBio Capital Management LP183,704$8.23M4.8%N/A0.238%Search for SEC Filing on Google Icon
2/16/2026Nicholas Investment Partners LP242,989$10.89M0.8%+104.0%0.314%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP17,025$0.76M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC600,964$26.94M0.0%+439.9%0.778%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC740$33K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP162,551$7.29M0.0%-73.4%0.210%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 32,622$1.45M0.0%+36.3%0.042%Search for SEC Filing on Google Icon
2/13/2026Walleye Capital LLC19,587$0.88M0.0%N/A0.025%Search for SEC Filing on Google Icon
2/13/2026Affinity Asset Advisors LLC1,250,000$56.03M3.2%-10.7%1.617%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp17,548$0.79M0.0%-6.2%0.023%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP6,361$0.29M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.189,059$8.47M0.0%+0.2%0.245%Search for SEC Filing on Google Icon
2/13/2026Police & Firemen s Retirement System of New Jersey20,128$0.90M0.0%-4.3%0.026%Search for SEC Filing on Google Icon
2/13/2026State Street Corp1,492,550$66.90M0.0%+1.8%1.931%Search for SEC Filing on Google Icon
2/13/2026Caitong International Asset Management Co. Ltd951$43K0.1%N/A0.001%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN152,297$6.83M0.0%+32.2%0.197%Search for SEC Filing on Google Icon
2/13/2026Rhenman & Partners Asset Management AB139,000$6.23M0.6%+71.6%0.180%Search for SEC Filing on Google Icon
2/12/2026Advisors Asset Management Inc.8,012$0.36M0.0%-30.1%0.010%Search for SEC Filing on Google Icon
2/12/2026Orion Porfolio Solutions LLC14,407$0.65M0.0%-3.4%0.019%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC42,025$1.88M0.0%-5.0%0.054%Search for SEC Filing on Google Icon
2/12/2026Cibc World Markets Corp5,027$0.23M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP452,147$20.26M0.0%-0.4%0.585%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.672,237$30.13M0.1%+189.1%0.870%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc5,194$0.23M0.0%-65.9%0.007%Search for SEC Filing on Google Icon
2/12/2026Marex Group plc10,557$0.47M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/12/2026Patient Square Capital LP136,500$6.12M1.3%N/A0.177%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund186,705$8.37M0.0%+8.7%0.242%Search for SEC Filing on Google Icon
2/12/2026Campbell & CO Investment Adviser LLC16,105$0.72M0.0%-43.8%0.021%Search for SEC Filing on Google Icon
2/12/2026Loomis Sayles & Co. L P612,032$27.43M0.0%-4.5%0.792%Search for SEC Filing on Google Icon
2/12/2026Alps Advisors Inc.63,302$2.84M0.0%+69.7%0.082%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank114,000$5.11M0.0%-9.8%0.148%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC216,238$9.69M0.0%-3.6%0.280%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG190,233$8.53M0.0%+68.4%0.246%Search for SEC Filing on Google Icon
2/11/2026Franklin Resources Inc.758,059$33.98M0.0%+8.9%0.981%Search for SEC Filing on Google Icon
2/11/2026Fiera Capital Corp686,056$30.75M0.1%+31.9%0.888%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.1,494,032$66.96M0.0%+6.8%1.933%Search for SEC Filing on Google Icon
2/11/2026Capital International Investors3,414,959$153.06M0.0%+7.3%4.419%Search for SEC Filing on Google Icon
2/11/2026Westfield Capital Management Co. LP1,226,771$54.98M0.2%+1.7%1.587%Search for SEC Filing on Google Icon
2/11/2026State of Wyoming1,501$67K0.0%+30.4%0.002%Search for SEC Filing on Google Icon
2/10/2026TD Asset Management Inc38,148$1.71M0.0%+135.0%0.049%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.696,047$31.20M0.0%-3.4%0.901%Search for SEC Filing on Google Icon
2/10/2026BNP Paribas Financial Markets93,462$4.19M0.0%-41.3%0.121%Search for SEC Filing on Google Icon
2/10/2026SBI Okasan Asset Management Co.Ltd.14,400$0.64M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC25,840$1.16M0.0%+11.9%0.033%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC952,679$42.69M0.0%-2.5%1.233%Search for SEC Filing on Google Icon
2/9/2026Clearstead Advisors LLC1,215$54K0.0%+214.8%0.002%Search for SEC Filing on Google Icon
2/6/2026Legato Capital Management LLC37,038$1.66M0.1%+160.7%0.048%Search for SEC Filing on Google Icon
2/6/2026PSP Research LLC11,678$0.52M0.5%N/A0.015%Search for SEC Filing on Google Icon
2/6/2026PNC Financial Services Group Inc.6,574$0.30M0.0%+11.4%0.009%Search for SEC Filing on Google Icon
2/6/2026Handelsbanken Fonder AB29,800$1.34M0.0%+31.3%0.039%Search for SEC Filing on Google Icon
2/6/2026TimesSquare Capital Management LLC532,740$23.88M0.4%-4.3%0.689%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC17,279$0.77M0.0%+9.8%0.022%Search for SEC Filing on Google Icon
2/5/2026DNB Asset Management AS272,831$12.23M0.0%+9.5%0.353%Search for SEC Filing on Google Icon
2/5/2026HighMark Wealth Management LLC23,000$1.03M0.4%-11.9%0.030%Search for SEC Filing on Google Icon
2/4/2026TLS Advisors LLC18,858$0.85M1.5%-42.8%0.024%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Xenon Pharmaceuticals logo
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN1101, a novel and potent Kv7 potassium channel opener, which is in Phase 3 clinical trials for the treatment of epilepsy and other neurological disorders. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase 2 clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Read More on Xenon Pharmaceuticals

Today's Range

Now: $54.94
Low: $54.51
High: $55.96

50 Day Range

MA: $45.04
Low: $39.98
High: $62.76

52 Week Range

Now: $54.94
Low: $26.74
High: $63.95

Volume

1,846,484 shs

Average Volume

2,233,750 shs

Market Capitalization

$4.57 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.91

Who are the company insiders with the largest holdings of Xenon Pharmaceuticals?

Xenon Pharmaceuticals' top insider investors include:
  1. Ian Mortimer (CEO)
  2. Gary Patou (Director)
  3. Andrea Difabio (Insider)
  4. Steven Gannon (Director)
  5. Christopher John Kenney (Insider)
  6. Sherry Aulin (CFO)
Learn More about top insider investors at Xenon Pharmaceuticals.

Who are the major institutional investors of Xenon Pharmaceuticals?

Xenon Pharmaceuticals' top institutional shareholders include:
  1. Avoro Capital Advisors LLC — 6.52%
  2. Janus Henderson Group PLC — 5.29%
  3. Capital International Investors — 4.42%
  4. Polar Capital Holdings Plc — 3.19%
  5. Braidwell LP — 2.36%
  6. Commodore Capital LP — 2.33%
Learn More about top institutional investors of Xenon Pharmaceuticals stock.

Which major investors are selling Xenon Pharmaceuticals stock?

During the last quarter, XENE stock was sold by these institutional investors:
  1. Braidwell LP
  2. Commodore Capital LP
  3. Millennium Management LLC
  4. Pictet Asset Management Holding SA
  5. T. Rowe Price Investment Management Inc.
  6. Vestal Point Capital LP
  7. Marshall Wace LLP
  8. Balyasny Asset Management L.P.
During the previous year, company insiders that have sold Xenon Pharmaceuticals company stock include:
  1. Ian Mortimer (CEO)
  2. Gary Patou (Director)
  3. Andrea Difabio (Insider)
  4. Steven Gannon (Director)
Learn More investors selling Xenon Pharmaceuticals stock.

Which major investors are buying Xenon Pharmaceuticals stock?

Within the last quarter, XENE stock was bought by institutional investors including:
  1. Price T Rowe Associates Inc. MD
  2. Caligan Partners LP
  3. Barclays PLC
  4. Federated Hermes Inc.
  5. Iron Triangle Partners LP
  6. Capital International Investors
  7. Eversept Partners LP
  8. Caption Management LLC